Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3921]
News [11368]
Articles [47]
Editorials [10]
Conferences [197]
elearning [4]
Disease control in advanced Hodgkin lymphoma
Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Disease control in advanced Hodgkin lymphoma ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018
Interim results of RELEVANCE trial in follicular lymphoma
Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France
Interim results of RELEVANCE trial in follicular lymphoma ( Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France )
15 Jun 2018
Update on bb2121 for relapsed myeloma
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Update on bb2121 for relapsed myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
15 Jun 2018
Mapping 3D genome dynamics in B cells
Dr José Ignacio Martin-Subero - University of Barcelona, Barcelona, Spain
Mapping 3D genome dynamics in B cells ( Dr José Ignacio Martin-Subero - University of Barcelona, Barcelona, Spain )
15 Jun 2018
Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results
Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018
Results from the phase I ICONIC trial
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
4 Jun 2018
Phase II results of olaparib and abiraterone for mCRPC
Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK
Phase II results of olaparib and abiraterone for mCRPC ( Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK )
4 Jun 2018
Design and interim safety analysis of GeparX trial
Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
Design and interim safety analysis of GeparX trial ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )
4 Jun 2018
Updates in melanoma from ASCO 2018
Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
Updates in melanoma from ASCO 2018 ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )
4 Jun 2018
Comment: Improved 2 year survival for pancreatic cancer with pre-operative...
Dr Andrew Epstein, Prof Richard Schilsky and Dr Geertjan van Tienhoven
Comment: Improved 2 year survival for pancreatic cancer with pre-operative chemoradiation ( Dr Andrew Epstein, Prof Richard Schilsky and Dr Geertjan van Tienhoven )
4 Jun 2018
Developing a survivin vaccine for glioblastoma
Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA
Developing a survivin vaccine for glioblastoma ( Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA )
3 Jun 2018
New pathways in pancreatic cancer
Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA
New pathways in pancreatic cancer ( Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA )
3 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation